Literature DB >> 2772204

Inferior vena cava: translumbar catheterization for central venous access.

D F Denny1, L H Greenwood, S S Morse, G K Lee, J Baquero.   

Abstract

In six patients who required long-term central venous access, translumbar catheterization of the inferior vena cava was performed seven times after the usual sites of access had become thrombosed. Four of the patients were male and two were female, and they ranged in age from 2 to 76 years. Placement of a 12-F Silastic catheter in one procedure, a 10-F catheter in three, a 9-F catheter in one, and a 7-F catheter in two was successful and uncomplicated. Of the three surviving patients, two had a functioning catheter at 1 week and 32 months, respectively; in the third patient the catheter was removed after 3 weeks, a few days after successful bowel surgery. Two patients with functioning catheters died, one of metastatic breast cancer after 12 months and the other of acquired immunodeficiency syndrome after 5 weeks. One patient twice required removal of a functioning catheter due to sepsis, the first after 3 weeks and the second after 6 weeks. These results show this technique to be safe and successful for selected patients.

Entities:  

Mesh:

Year:  1989        PMID: 2772204     DOI: 10.1148/172.3.1013

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  2 in total

1.  Percutaneous translumbar inferior vena cava cannulation under computed tomography guidance.

Authors:  Shuji Kariya; Noboru Tanigawa; Hiroyuki Kojima; Atsushi Komemushi; Yuzo Shomura; Sang Kil Ha-Kawa; Takanori Tokuda; Minoru Kamata; Satoshi Sawada
Journal:  Jpn J Radiol       Date:  2009-06-06       Impact factor: 2.374

2.  The vanishing veins: difficult venous access in a patient requiring translumbar, transhepatic, and transcollateral central catheter insertion.

Authors:  Yazmin Yaacob; Rozman Zakaria; Zahiah Mohammad; Ahmad Razali Md Ralib; Ahmad Sobri Muda
Journal:  Malays J Med Sci       Date:  2011-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.